227 related articles for article (PubMed ID: 25714858)
1. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH.
Di Nisio M; Lee AY; Carrier M; Liebman HA; Khorana AA;
J Thromb Haemost; 2015 May; 13(5):880-3. PubMed ID: 25714858
[No Abstract] [Full Text] [Related]
2. Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
Rouzaud D; Alexandra JF; Chauchard M; Delon M; Dossier A; Chauveheid MP; Perozziello A; Papo T; Sacre K
Thromb Res; 2016 Aug; 144():116-8. PubMed ID: 27322086
[No Abstract] [Full Text] [Related]
3. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH.
Khorana AA; Otten HM; Zwicker JI; Connolly GC; Bancel DF; Pabinger I;
J Thromb Haemost; 2014 Nov; 12(11):1928-31. PubMed ID: 25208230
[No Abstract] [Full Text] [Related]
4. Treatment of venous thromboembolism in cancer patients.
Lee AY
Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276
[TBL] [Abstract][Full Text] [Related]
5. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.
Khorana AA; Noble S; Lee AYY; Soff G; Meyer G; O'Connell C; Carrier M
J Thromb Haemost; 2018 Sep; 16(9):1891-1894. PubMed ID: 30027649
[No Abstract] [Full Text] [Related]
6. Management of venous thromboembolism in patients with cancer.
Noble S; Jenkins DA
Br J Hosp Med (Lond); 2009 Jul; 70(7):380-5. PubMed ID: 19584778
[TBL] [Abstract][Full Text] [Related]
7. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH.
Martin K; Beyer-Westendorf J; Davidson BL; Huisman MV; Sandset PM; Moll S
J Thromb Haemost; 2016 Jun; 14(6):1308-13. PubMed ID: 27299806
[No Abstract] [Full Text] [Related]
8. The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients.
Streiff MB;
Thromb Res; 2010 Apr; 125 Suppl 2():S128-33. PubMed ID: 20433992
[No Abstract] [Full Text] [Related]
9. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH: reply.
Khorana AA; Zwicker JI; Connolly GC; Pabinger I
J Thromb Haemost; 2015 Feb; 13(2):325-6. PubMed ID: 25408162
[No Abstract] [Full Text] [Related]
10. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH: comment.
Oo TH
J Thromb Haemost; 2015 Feb; 13(2):323-4. PubMed ID: 25308159
[No Abstract] [Full Text] [Related]
11. Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH.
Di Nisio M; Carrier M; Lyman GH; Khorana AA;
J Thromb Haemost; 2014 Oct; 12(10):1746-9. PubMed ID: 25099690
[No Abstract] [Full Text] [Related]
12. Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH.
Male C; Monagle P; Chan AK; Young G;
J Thromb Haemost; 2015 Mar; 13(3):481-4. PubMed ID: 25472419
[No Abstract] [Full Text] [Related]
13. Venous thromboembolism prophylaxis and treatment in patients with cancer.
Kakkar AK
Clin Adv Hematol Oncol; 2008 Jun; 6(6):416-7. PubMed ID: 18567985
[No Abstract] [Full Text] [Related]
14. Biomarkers of venous thromboembolism in cancer: a silent echo from local events?
Gezelius E; Belting M
Biomark Med; 2019 May; 13(7):507-509. PubMed ID: 31140831
[No Abstract] [Full Text] [Related]
15. Antithrombotic therapy and survival in cancer patients.
Kakkar AK
Best Pract Res Clin Haematol; 2009 Mar; 22(1):147-51. PubMed ID: 19285281
[TBL] [Abstract][Full Text] [Related]
16. The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH.
Tullius BP; Athale U; van Ommen CH; Chan AKC; Palumbo JS; Balagtas JMS;
J Thromb Haemost; 2018 Jan; 16(1):175-180. PubMed ID: 29178421
[No Abstract] [Full Text] [Related]
17. The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH.
Zwicker JI; Wang TF; DeAngelo DJ; Lauw MN; Connors JM; Falanga A; McMasters M; Carrier M
J Thromb Haemost; 2020 Feb; 18(2):278-284. PubMed ID: 31999063
[TBL] [Abstract][Full Text] [Related]
18. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation.
Martin KA; Beyer-Westendorf J; Davidson BL; Huisman MV; Sandset PM; Moll S
J Thromb Haemost; 2021 Aug; 19(8):1874-1882. PubMed ID: 34259389
[TBL] [Abstract][Full Text] [Related]
19. Management of Cancer-Associated Venous Thromboembolism in the Emergency Department.
Nene RV; Coyne CJ
Ann Emerg Med; 2017 Jun; 69(6):768-776. PubMed ID: 28169053
[TBL] [Abstract][Full Text] [Related]
20. Management of cancer-associated thromboembolism: Introduction.
Mahé I; Sanchez O; Mismetti P
Arch Cardiovasc Dis; 2024 Jan; 117(1):3-5. PubMed ID: 38087662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
